The crucial role of payload linker innovation in the growth of ADCs
Combining the specificity of monoclonal antibodies with the potency of cytotoxic payloads, ADCs enable targeted delivery of therapeutics to diseased…
Combining the specificity of monoclonal antibodies with the potency of cytotoxic payloads, ADCs enable targeted delivery of therapeutics to diseased…
AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved data quality. Nowhere is this…
The newest generation of AI-driven tools is beginning to reshape how clinical databases are built, governed, and maintained. This is…
In recent years, the pharmaceutical industry has seen a significant increase in the development of highly potent active pharmaceutical ingredients…
This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by…
Clinical trials are producing more data than ever before, drawing from vast and diverse datasets that must be cleaned and…
As the clinical trial industry faces key challenges such as shifts, rising costs, and staffing challenges, 2026 is poised to…
Vertical integration of contract development and manufacturing organisations (CDMOs) involved in antibody-drug conjugates (ADCs) manufacturing has the potential to streamline…
Real-world data (RWD) is transforming healthcare by the changing priorities of pharma companies and the growing influence of AI, with…
Pharma supply chains are under enormous pressure globally, with geopolitical tensions and the issue of tariffs requiring careful management by…